98%
921
2 minutes
20
Connective tissue diseases (CTD) encompass a heterogeneous group of systemic immune-mediated disorders affecting connective tissue throughout the body. Pulmonary involvement is a common and clinically significant manifestation of CTD, with interstitial lung disease (ILD) representing a major contributor to both morbidity and mortality. Therefore, early detection of CTD-ILD is critical, and a multidisciplinary approach is paramount for both diagnosis and patient management. In this context, high-resolution computed tomography (HRCT) plays a pivotal role not only in recognizing characteristic ILD patterns but also in monitoring disease progression and guiding further management. Although the most frequent imaging pattern in CTD-ILD is nonspecific interstitial pneumonia (NSIP), the spectrum of pulmonary manifestations is complex and heterogeneous. Other patterns such as usual interstitial pneumonia (UIP), organizing pneumonia (OP), lymphocytic interstitial pneumonia (LIP), and diffuse alveolar damage (DAD) can also occur, showing distinct associations with specific CTD. Moreover, overlap and transition between patterns are not uncommon, further complicating the diagnostic process. This review aims to provide a comprehensive overview of the most relevant pulmonary manifestations of CTD, particularly ILD, with a focus on HRCT-based pattern recognition in order to enhance radiologist's familiarity with their spectrum of imaging appearances.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00117-025-01492-4 | DOI Listing |
Radiol Res Pract
August 2025
Department of Radiology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Idiopathic interstitial pneumonias (IIPs) are widespread interstitial lung diseases with no known cause. The diseases are characterized by a steady decline in lung function. To assess the patterns of IIPs and investigate the correlation between the extents of lung involvement on high-resolution computed tomography (HRCT) with spirometric findings in Tikur Anbessa Specialized Hospital (TASH) chest clinic, covering the period from February 2020 to February 2023.
View Article and Find Full Text PDFGastro Hep Adv
June 2025
Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Background And Aims: Gastroesophageal reflux (GER) is common and thought to contribute to disease progression in patients with respiratory disease. Delayed gastric emptying (DGE) can increase GER in patients with GER disease, but its effect in patients with respiratory disease, and how differing lung structure (eg, scarring, inflammation) and mechanics (eg, decreased thoracic pressure in restrictive disease, increased abdominal pressure in obstructive disease) influences this is unknown. Our aim was to understand these interrelationships and association with pulmonary function in patients with chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease (non-IPF ILD).
View Article and Find Full Text PDFMultidiscip Respir Med
September 2025
Department of Chest Diseases, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Background: Chest examination alone may be insufficient to declare cardiorespiratory diseases specially in its early stages and/or silent forms, also it is impractical for the CXR and cardiac consultation to be requested for every patient in the outpatient clinic, therefore involving the chest US and FoCUS (Focused Cardiac Ultra Sound) examination in the bedside practice of outpatient chest clinic may influence the clinical diagnosis and management plan.
Objective: To determine how the bedside thoracic US including FoCUS can alter the clinical diagnosis in patients who are clinically diagnosed as acute bronchitis in the outpatient chest clinic.
Subjects And Methods: This study was conducted at Chest outpatient clinic, Al-Azhar University in the period between January 2024 to March 2025.
Nan Fang Yi Ke Da Xue Xue Bao
August 2025
Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
Objectives: To investigate the effect of (HP) on bleomycin (BLM)-induced pulmonary fibrosis in mice and on TGF-β1-induced human fetal lung fibroblasts (HFL1).
Methods: Thirty male C57BL/6 mice were randomly divided into control group, BLM-induced pulmonary fibrosis model group, low- and high-dose HP treatment groups (3 and 21 mg/kg, respectively), and 300 mg/kg pirfenidone (positive control) group. The effects of drug treatment for 21 days were assessed by examining respiratory function, lung histopathology, and expression of fibrosis markers in the lung tissues of the mouse models.
Ther Adv Respir Dis
September 2025
Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Background: Hermansky-Pudlak syndrome (HPS) is a rare disease characterized by excessive bleeding, oculocutaneous albinism, and pulmonary fibrosis (PF). However, few studies have systematically summarized the clinical characteristics of HPS.
Objectives: To summarize the clinical characteristics, risk factors of PF, radiological and pathological presentations, and prognostic factors in patients with HPS.